Sigachi Industries’ wholly owned subsidiary -- Sigachi MENA FZCO has signed a memorandum of understanding (MoU) with Respilon Group s.r.o. The partnership aims to leverage Respilon’s NUENEX nanofiber technology to transform patient experience and therapeutic outcomes through non-invasive, precision drug delivery.
Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery solutions based on Respilon’s proprietary NUENEX nanofiber technology; and focus on the development of Invisible Patch and Powder-based pharmaceutical delivery formats. The collaboration includes developing commercialization strategies for relevant APIs and formulations, leveraging nanofiber encapsulation technology.
Sigachi Industries is an industry leader in the field of Pharma Excipients, Nutra and food ingredients. The company has rapidly established itself as one of the largest manufacturers of Microcrystalline Cellulose worldwide.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.25 |
| Dr. Reddys Labs. | 1245.50 |
| Cipla | 1438.75 |
| Zydus Lifesciences | 1150.50 |
| Lupin | 2496.05 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: